Skip to main content

Advertisement

SpringerLink
Log in

Establishment of a bioluminescent Renca cell line for renal carcinoma research

  • Urology – Original Paper
  • Published:
International Urology and Nephrology Aims and scope Submit manuscript

Abstract

Purpose

Luciferase modification of tumour cells enables early and non-invasive imaging to detect tumour growth in situ and could provide sensitive and effective detection of carcinoma during research and therapy.

Methods

Renca cells, a murine renal carcinoma cell line, were infected with lentivirus expressing luciferase to obtain Renca-luc. The proliferation, invasion, and migration of Renca and Renca-luc cell lines were compared using colorimetric, Boyden chamber, and wound-healing assays. Orthotopic tumour models were established in BALB/c mice using Renca and Renca-luc cells, and tumour growth in vivo was detected using bioluminescence imaging and magnetic resonance imaging (MRI).

Results

Intensity of luciferase signals from Renca-luc was positively correlated with cell number. Bioluminescence signal was detected 1 day after the establishment of the renal carcinoma model using Renca-luc and was significantly increased after 7 days. Tumour size at 7 days following the establishment of renal carcinoma models using Renca and Renca-luc was determined using MRI. The presence of renal model tumours was confirmed by histological staining. The expression of luciferase did not affect Renca cell characteristics in vitro or tumour growth in vivo.

Conclusion

Luciferase labelling could provide a sensitive and non-invasive evaluation method for immunological and tumour therapy of renal carcinomas.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5
Fig. 6

Similar content being viewed by others

Abbreviations

MRI:

Magnetic resonance imaging

BLI:

Bioluminescence imaging

RC:

Renal carcinoma

Renca-luc:

luc2-labelled Renca line

References

  1. Siegel RL, Miller KD, Jemal A (2017) Cancer statistics, 2017. CA Cancer J Clin 67(1):7–30. doi:10.3322/caac.21387

    Article  PubMed  Google Scholar 

  2. Siegel RL, Miller KD, Jemal A (2016) Cancer statistics, 2016. CA Cancer J Clin 66(1):7–30. doi:10.3322/caac.21332

    Article  PubMed  Google Scholar 

  3. Chen W (2015) Cancer statistics: updated cancer burden in China. Chin J Cancer Res 27(1):1. doi:10.3978/j.issn.1000-9604.2015.02.07

    PubMed  PubMed Central  Google Scholar 

  4. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66(2):115–132. doi:10.3322/caac.21338

    Article  PubMed  Google Scholar 

  5. Cancer Genome Atlas Research Network (2013) Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499(7456):43–49. doi:10.1038/nature12222

    Article  Google Scholar 

  6. Chen W, Hill H, Christie A, Kim MS, Holloman E, Pavia-Jimenez A, Homayoun F, Ma Y, Patel N, Yell P, Hao G, Yousuf Q, Joyce A, Pedrosa I, Geiger H, Zhang H, Chang J, Gardner KH, Bruick RK, Reeves C, Hwang TH, Courtney K, Frenkel E, Sun X, Zojwalla N, Wong T, Rizzi JP, Wallace EM, Josey JA, Xie Y, Xie XJ, Kapur P, McKay RM, Brugarolas J (2016) Targeting renal cell carcinoma with a HIF-2 antagonist. Nature 539(7627):112–117. doi:10.1038/nature19796

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Ukon N, Zhao S, Yu W, Shimizu Y, Nishijima KI, Kubo N, Kitagawa Y, Tamaki N, Higashikawa K, Yasui H, Kuge Y (2016) Dynamic PET evaluation of elevated FLT level after sorafenib treatment in mice bearing human renal cell carcinoma xenograft. EJNMMI Res 6(1):90. doi:10.1186/s13550-016-0246-z

    Article  PubMed  PubMed Central  Google Scholar 

  8. Zhao H, Nolley R, Chan AM, Rankin EB, Peehl DM (2016) Cabozantinib inhibits tumor growth and metastasis of a patient-derived xenograft model of papillary renal cell carcinoma with MET mutation. Cancer Biol Ther. doi:10.1080/15384047.2016.1219816

    Google Scholar 

  9. Asadzadeh F, Ferrucci V, De Antonellis P, Zollo M (2017) In vivo bioluminescence imaging using orthotopic xenografts towards patient’s derived-xenograft Medulloblastoma models. Q J Nucl Med Mol Imaging Off Publ Ital Assoc Nucl Med 61(1):95–101. doi:10.23736/S1824-4785.16.02959-9

    Google Scholar 

  10. Jones L, Richmond J, Evans K, Carol H, Jing D, Kurmasheva RT, Billups CA, Houghton PJ, Smith MA, Lock RB (2017) Bioluminescence imaging enhances analysis of drug responses in a patient-derived xenograft model of pediatric ALL. Clin Cancer Res. doi:10.1158/1078-0432.CCR-16-2392

    Google Scholar 

  11. Ramasawmy R, Johnson SP, Roberts TA, Stuckey DJ, David AL, Pedley RB, Lythgoe MF, Siow B, Walker-Samuel S (2016) Monitoring the growth of an orthotopic tumour xenograft model: multi-modal imaging assessment with benchtop MRI (1T), high-field MRI (9.4T), ultrasound and bioluminescence. PLoS ONE 11(5):e0156162. doi:10.1371/journal.pone.0156162

    Article  PubMed  PubMed Central  Google Scholar 

  12. Au JT, Gonzalez L, Chen CH, Serganova I, Fong Y (2012) Bioluminescence imaging serves as a dynamic marker for guiding and assessing thermal treatment of cancer in a preclinical model. Ann Surg Oncol 19(9):3116–3122. doi:10.1245/s10434-012-2313-7

    Article  PubMed  Google Scholar 

  13. Schafer H, Schafer A, Kiderlen AF, Masihi KN, Burger R (1997) A highly sensitive cytotoxicity assay based on the release of reporter enzymes, from stably transfected cell lines. J Immunol Methods 204(1):89–98

    Article  CAS  PubMed  Google Scholar 

  14. Chen H, Yao H, Huang L, Shen Q, Jia W, Xue J (2006) Expression of human factor IX gene in murine plasma through lentiviral vector-infected haematopoietic stem cells. Clin Exp Pharmacol Physiol 33(12):1196–1201. doi:10.1111/j.1440-1681.2006.04511.x

    Article  CAS  PubMed  Google Scholar 

  15. Ding J, Wang C, Li PC, Zhao Z, Qian C, Wang CX, Cai Y, Teng GJ (2016) Dual-reporter imaging and its potential application in tracking studies. J Fluoresc 26(1):75–80. doi:10.1007/s10895-015-1673-3

    Article  CAS  PubMed  Google Scholar 

  16. Ding J, Zhao Z, Wang C, Wang CX, Li PC, Qian C, Teng GJ (2016) Bioluminescence imaging of transplanted human endothelial colony-forming cells in an ischemic mouse model. Brain Res 1642:209–218. doi:10.1016/j.brainres.2016.03.045

    Article  CAS  PubMed  Google Scholar 

  17. Wang H, Wang H, Shen W, Huang H, Hu L, Ramdas L, Zhou YH, Liao WS, Fuller GN, Zhang W (2003) Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes. Can Res 63(15):4315–4321

    CAS  Google Scholar 

  18. Wang J, Wang H, Zhu R, Liu Q, Fei J, Wang S (2015) Anti-inflammatory activity of curcumin-loaded solid lipid nanoparticles in IL-1β transgenic mice subjected to the lipopolysaccharide-induced sepsis. Biomaterials 53:475–483. doi:10.1016/j.biomaterials.2015.02.116

    Article  CAS  PubMed  Google Scholar 

  19. Wang X, McManus M (2009) Lentivirus production. J Vis Exp. doi:10.3791/1499

    Google Scholar 

  20. Ding J, Wang C, Li PC, Zhao Z, Qian C, Wang CX, Cai Y, Teng GJ (2015) Dual-reporter imaging and its potential application in tracking studies. J Fluoresc. doi:10.1007/s10895-015-1673-3

    Google Scholar 

  21. Vogelzang NJ, Stadler WM (1998) Kidney cancer. Lancet 352(9141):1691–1696. doi:10.1016/S0140-6736(98)01041-1

    Article  CAS  PubMed  Google Scholar 

  22. Gupta K, Miller JD, Li JZ, Russell MW, Charbonneau C (2008) Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): a literature review. Cancer Treat Rev 34(3):193–205. doi:10.1016/j.ctrv.2007.12.001

    Article  PubMed  Google Scholar 

  23. Siegel R, Naishadham D, Jemal A (2012) Cancer statistics, 2012. CA Cancer J Clin 62(1):10–29. doi:10.3322/caac.20138

    Article  PubMed  Google Scholar 

  24. Escudier B (2010) Chemo-immunotherapy in RCC: the end of a story. Lancet 375(9715):613–614. doi:10.1016/S0140-6736(10)60209-7

    Article  PubMed  Google Scholar 

  25. Longo R, D’Andrea MR, Sarmiento R, Salerno F, Gasparini G (2007) Integrated therapy of kidney cancer. Ann Oncol 18(Suppl 6):vi141–vi148. doi:10.1093/annonc/mdm244

    PubMed  Google Scholar 

  26. Atkins MB, Ernstoff MS, Figlin RA, Flaherty KT, George DJ, Kaelin WG Jr, Kwon ED, Libermann TA, Linehan WM, McDermott DF, Ochoa AC, Pantuck AJ, Rini BI, Rosen MA, Sosman JA, Sukhatme VP, Vieweg JW, Wood CG, King L (2007) Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge Conference. Clin Cancer Res 13(2 Pt 2):667s–670s. doi:10.1158/1078-0432.CCR-06-2231

    Article  PubMed  Google Scholar 

  27. Sadikot RT, Blackwell TS (2005) Bioluminescence imaging. Proc Am Thorac Soc 2(6):537–540, 511–532. doi:10.1513/pats.200507-067DS

Download references

Acknowledgements

This research was supported by the Fundamental Research Funds for the Central Universities (No. 2242015k30002). We also thank Adam & Stone Bio-Medicals Ltd Co. for English editing.

Author information

Authors and Affiliations

  1. Jiangsu Key Laboratory of Molecular and Functional Imaging, Department of Radiology, Zhongda Hospital, Medical School, Southeast University, #87 Dingjiaqiao Road, Nanjing, 210009, China

    Jie Ding & Xiaofeng Chang

  2. Education Ministry’s Key Laboratory of Developmental Genes and Human Diseases, Institute of Life Sciences, Southeast University, #2 Sipailou, Nanjing, 210096, China

    Chao Wang

  3. Department of Urology, Nanjing Drum Tower Hospital, The Affiliated Hospital of Nanjing University, #321 Zhongshan Road, Nanjing, 210008, China

    Xiaofeng Chang

Authors
  1. Jie Ding
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Chao Wang
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaofeng Chang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

J. Ding conducted all experiments and edited figures; C. Wang integrated data and wrote the manuscript; X. Chang provided essential assistance. All authors discussed the results and approved the manuscript.

Corresponding author

Correspondence to Jie Ding.

Ethics declarations

Conflict of interest

There are no conflicts of interest to declare.

Ethical approval

The study design was approved by the appropriate ethics review boards. Animal experiments were carried out in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals and were approved by the Laboratory Animal Center of Southeast University.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary material 1 (TIFF 169 kb)

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Ding, J., Wang, C. & Chang, X. Establishment of a bioluminescent Renca cell line for renal carcinoma research. Int Urol Nephrol 50, 55–61 (2018). https://doi.org/10.1007/s11255-017-1707-7

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11255-017-1707-7

Keywords

Search

Navigation